Abstract:Cytoplasmic export of the RNA-binding protein HuR, a process that critically regulates its function, was recently shown to be inhibited by the AMP-activated protein kinase ( AMPK). In the present investigation, treatment of human fibroblasts with AMPK activators such as 5-amino-imidazole-4-carboxamide riboside, antimycin A, and sodium azide inhibited cell growth and lowered the expression of proliferative genes. As anticipated, AMPK activation also decreased both the cytoplasmic HuR levels and the association of HuR with target radiolabeled transcripts encoding such proliferative genes. HuR function was previously shown to be implicated in the maintenance of a "young cell" phenotype in models of replicative cellular senescence. We therefore postulated that AMPK activation in human fibroblasts might contribute to the implementation of the senescence phenotype through mechanisms that included a reduction in HuR cytoplasmic presence. Indeed, AMP: ATP ratios were 2 -3-fold higher in senescent fibroblasts compared with young fibroblasts. Accordingly, in vitro senescence was accompanied by a marked elevation in AMPK activity. Evidence that increased AMPK activity directly contributed to the implementation of the senescent phenotype was obtained through two experimental approaches. First, use of AMPK activators triggered senescence characteristics in fibroblasts, such as the acquisition of senescence-associated beta-galactosidase (beta-gal) activity and increased p16(INK4a) expression. Second, infection of cells with an adenoviral vector that expresses active AMPK increased senescence-associated beta-gal activity, whereas infection with an adenovirus that expresses dominant-negative AMPK decreased senescence-associated beta-gal activity. Together, our results indicate that AMPK activation can cause premature fibroblast senescence through mechanisms that likely involve reduced HuR function.

HuR Uses AUF1 As a Cofactor to Promote P16ink4 Mrna Decay

Reduced nuclear export of HuR mRNA by HuR is linked to the loss of HuR in replicative senescence.

Increased Stability of the P16 Mrna with Replicative Senescence

Hydrogen peroxide induces p16(INK4a) through an AUF1-dependent manner

Loss of CARM1 is linked to reduced HuR function in replicative senescence

HuR stabilizes HTT mRNA via interacting with its exon 11 in a mutant HTT-dependent manner.

Amp-Activated Kinase Regulates Cytoplasmic Hur

HuR controls apoptosis and activation response without effects on cytokine 3’ UTRs

HuR and post-transcriptional regulation in vascular aging

The Molecular Mechanism of Y473 Phosphorylation of UGDH Relieves the Inhibition Effect of UDP-glucose on HuR.

RNA-binding protein HuR inhibition induces multiple programmed cell death in breast and prostate cancer

HuR Stabilizes TFAM Mrna in an ATM/p38‐dependent Manner in Ionizing Irradiated Cancer Cells

Modulation of the expression of p16INK4a and p14ARF by hnRNP A1 and A2 RNA binding proteins: Implications for cellular senescence

Loss of Repression of HuR Translation by Mir‐16 May Be Responsible for the Elevation of HuR in Human Breast Carcinoma

Targeting the RNA-binding protein HuR in cancer.

Human antigen R and drug resistance in tumors

HuR (ELAVL1) Stabilizes SOX9 mRNA and Promotes Migration and Invasion in Breast Cancer Cells

Increased Amp : Atp Ratio And Amp-Activated Protein Kinase Activity During Cellular Senescence Linked To Reduced Hur Function

Mechanism of Strong Inhibition of HNF4α1 Protein Expression by Its 5' UTR (749.7)

HuR, a Key Post-Transcriptional Regulator, and Its Implication in Progression of Breast Cancer.